Chloé Laurencin

Publications

Article dans une revue (36)

Motor complications and postural abnormalities interplay in Parkinson's disease Margherita Fabbri,Aymeric Lanore,Nathalie Bertille,Jean-Christophe Corvol,Olivier Rascolet al. Parkinsonism & Related Disorders, 2026, 142, pp.108124. ⟨10.1016/j.parkreldis.2025.108124⟩ Article dans une revue hal-05391244v1
Effects of deep brain stimulation on non motor fluctuations in Parkinson’s disease (assessed with the NMF severity scale) Christian Matta,Camille Comet,Corentin Gaillard,Florent Faggianelli,Stephan Grimaldiet al. Clinical Parkinsonism & Related Disorders, 2026, 14, pp.100426. ⟨10.1016/j.prdoa.2026.100426⟩ Article dans une revue hal-05510245v1
DBS-related infections in Parkinson's disease: Incidence, risk factors, management and outcome M. Desnoyers,M. Bonjour,E. Metereau,T. Danaila,C. Laurencinet al. Revue Neurologique, 2026, ⟨10.1016/j.neurol.2026.01.006⟩ Article dans une revue hal-05514260v1
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease Mathilde Boussac,Florent Faggianelli,Estelle Harroch,Alexandre Eusebio,Margherita Fabbriet al. Journal of Parkinson's disease, 2025, 15 (5), pp.1007-1018. ⟨10.1177/1877718X251354932⟩ Article dans une revue hal-05144998v1
Demyelinating neuropathy as the initial presentation of familial E200K Creutzfeldt–Jakob disease in two patients Cécile Delorme,Antoine Pégat,Julian Theuriet,Jean-Philippe Brandel,Emmanuel Rozeet al. Annals of Clinical and Translational Neurology, 2025, ⟨10.1002/acn3.52296⟩ Article dans une revue hal-04929178v1
Neuropsychiatric fluctuations in Parkinson's disease: A French multicenter study of the NFS psychometric properties Emmanuelle Schmitt,Martine Bouvard,Mathieu Anheim,Dominique Guehl,Hélène Klingeret al. Parkinsonism & Related Disorders, 2025, 138, pp.107954. ⟨10.1016/j.parkreldis.2025.107954⟩ Article dans une revue hal-05185268v1
Validation of the French Translation of the Movement Disorder Society Non‐Motor Symptoms Scale ( MDS ‐ NMS ) in Parkinson's Disease Clément Desjardins,Stéphan Grimaldi,Sheng Luo,Luowen Yu,Christopher Goetzet al. Movement Disorders Clinical Practice, 2025, 13, pp.575-579. ⟨10.1002/mdc3.70323⟩ Article dans une revue hal-05240709v1
Deep Brain Stimulation in Classical Galactosemia: A Case‐Report Nolwenn Billet,Emile Simon,Chloé Laurencin,Adelaide Jaulent,Paul Jaulentet al. Movement Disorders Clinical Practice, 2025, ⟨10.1002/mdc3.70180⟩ Article dans une revue hal-05133213v1
Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta‐analysis of an N‐of‐1 trial Chloé Laurencin,Aurelia Poujois,Maxime Bonjour,Caroline Demily,Hélène Klingeret al. European Journal of Neurology, 2024, 32 (1), ⟨10.1111/ene.16524⟩ Article dans une revue hal-04929461v1
PSP‐Richardson 's Syndrome as a Rare Phenotypic Expression of Very Late‐Onset Huntington's Disease: A Case Report Stéphane Prange,Chloé Laurencin,Pauline Roche,Isabelle Quadrio,Stéphane Thobois Movement Disorders Clinical Practice, 2024, 11 (3), pp.303-305. ⟨10.1002/mdc3.13943⟩ Article dans une revue hal-04801803v1
Globus Pallidus Lesion With Iron Deposition and Dopaminergic Denervation in a Patient With a Pathogenic SLC6A1 Variant Victoire Leclert,Chloe Laurencin,Roxana Ameli,Marc Hermier,Anthime Flauset al. Neurology Genetics, 2024, 10 (2), pp.799-811. ⟨10.1212/NXG.0000000000200136⟩ Article dans une revue hal-04928946v1
Noradrenergic alterations in Parkinson's disease: a combined 11 C-yohimbine PET/neuromelanin MRI study Chloé Laurencin,Sophie Lancelot,Sarah Brosse,Inés Mérida,Jérôme Redoutéet al. Brain - A Journal of Neurology , 2024, 147 (4), pp.1377-1388. ⟨10.1093/brain/awad338⟩ Article dans une revue hal-04441098v3
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial Chloé Laurencin,Noémie Timestit,Ana Marques,Domitille Dilly Duchez,Caroline Giordanaet al. Journal of Neurology, 2023, 270, pp.4851 - 4859. ⟨10.1007/s00415-023-11814-y⟩ Article dans une revue hal-04274916v1
Diagnosis and Outcomes of Late‐Onset Wilson's Disease: A National Registry‐Based Study Christelle Nilles,Mickael Alexandre Obadia,Rodolphe Sobesky,Jérôme Dumortier,Olivier Guillaudet al. Movement Disorders, 2023, 38 (2), pp.321-332. ⟨10.1002/mds.29292⟩ Article dans une revue hal-04183831v1
Distribution of α 2 -Adrenergic Receptors in the Living Human Brain Using [ 11 C]yohimbine PET Chloé Laurencin,Sophie Lancelot,Inès Merida,Nicolas Costes,Jérôme Redoutéet al. Biomolecules, 2023, 13 (5), pp.843. ⟨10.3390/biom13050843⟩ Article dans une revue (data paper) hal-04098859v1
Clinical and Electrophysiological Characterization of Essential Tremor in 18 Children and Adolescents Julie Piarroux,Evgenia Dimopoulou,Guillaume Taieb,Sarah Souvannanorath,Emmanuel Rozeet al. Tremor and Other Hyperkinetic Movements, 2023, 13, pp.46. ⟨10.5334/tohm.803⟩ Article dans une revue hal-04383318v1
Quantification of Head Tremors in Medical Conditions: A Comparison of Analyses Using a 2D Video Camera and a 3D Wireless Inertial Motion Unit David Amarantini,Isabelle Rieu,Giovanni Castelnovo,Frederique Fluchere,Chloe Laurencinet al. Sensors, 2022, 22 (6), pp.2385. ⟨10.3390/s22062385⟩ Article dans une revue hal-03634261v1
Botulinum toxin injections are an effective treatment for patients with essential head tremor Ana Marques,Isabelle Rieu,Bruno Pereira,Giovanni Castelnovo,Frédérique Fluchèreet al. Movement Disorders, 2022, 37 (Suppl. 2), pp.S425 Article dans une revue hal-04367745v1
Limbic Stimulation Drives Mania in STN-DBS in Parkinson Disease: A Prospective Study Stéphane Prange,Zhengyu Lin,Mikail Nourredine,Teodor Danaila,Chloé Laurencinet al. Annals of Neurology, 2022, 92 (3), pp.411-417. ⟨10.1002/ana.26434⟩ Article dans une revue hal-04222081v1
Personality Assessment with Temperament and Character Inventory in Parkinson's Disease. Mathilde Boussac,Christophe Arbus,Olivier Colin,Chloé Laurencin,Alexandre Eusebioet al. Parkinsonism & Related Disorders, 2022, 103, pp.34--41. ⟨10.1016/j.parkreldis.2022.08.004⟩ Article dans une revue hal-03767971v1
Maintenance therapy simplification using a single daily dose: A preliminary real-life feasibility study in patients with Wilson disease Olivier Guillaud,France Woimant,Eduardo Couchonnal,Jérôme Dumortier,Chloe Laurencinet al. Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (9), pp.101978. ⟨10.1016/j.clinre.2022.101978⟩ Article dans une revue hal-04183809v1
Noradrenaline and Movement Initiation Disorders in Parkinson’s Disease: A Pharmacological Functional MRI Study with Clonidine Marion Criaud,Chloé Laurencin,Alice Poisson,Elise Metereau,Jérôme Redoutéet al. Cells, 2022, 11 (17), pp.2640. ⟨10.3390/cells11172640⟩ Article dans une revue hal-03800390v1
Modeling [11C]yohimbine PET human brain kinetics with test-retest reliability, competition sensitivity studies and search for a suitable reference region Chloé Laurencin,Sophie Lancelot,Florent Gobert,Jérôme Redouté,Inés Méridaet al. NeuroImage, 2021, 240, pp.118328. ⟨10.1016/j.neuroimage.2021.118328⟩ Article dans une revue hal-03280093v1
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study Marie Des Neiges Santin,Paul Voulleminot,Agathe Vrillon,Elodie Hainque,Matthieu Bereauet al. Movement Disorders, 2021, 36 (3), pp.750-757. ⟨10.1002/mds.28320⟩ Article dans une revue hal-03228822v1
Feasibility of changing for a rechargeable constant current neurostimulator in Parkinson's disease Thomas Wirth,Chloe Laurencin,J. Berthillier,A. Brinzeu,G. Poloet al. Revue Neurologique, 2020, 177 (3), pp.283-289. ⟨10.1016/j.neurol.2020.02.007⟩ Article dans une revue hal-03714792v1
The blood copper isotopic composition is a prognostic indicator of the hepatic injury in Wilson disease Aline Lamboux,Eduardo Couchonnal-Bedoya,Olivier Guillaud,Chloé Laurencin,Laurence Lion-Françoiset al. Metallomics, 2020, 12 (11), pp.1781-1790. ⟨10.1039/d0mt00167h⟩ Article dans une revue hal-03044206v1
KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation Laura Cif,Diane Demailly,Jean-Pierre Lin,Katy Barwick,Mario Saet al. Brain - A Journal of Neurology , 2020, 143 (11), pp.3242-3261. ⟨10.1093/brain/awaa304⟩ Article dans une revue hal-02992682v1
Functional imaging studies of Impulse Control Disorders in Parkinson’s disease need a stronger neurocognitive footing Garance Meyer,Charlotte Spay,Chloé Laurencin,Benedicte Ballanger,Guillaume Sescousseet al. Neuroscience and Biobehavioral Reviews, 2019, 98, pp.164-176. ⟨10.1016/j.neubiorev.2019.01.008⟩ Article dans une revue hal-02114093v1
A novel heterozygous ANO3 mutation responsible for myoclonic dystonia Chloé Laurencin,Emmanuel Broussolle,Teodor Danaila,Mathieu Anheim,Jamel Chellyet al. J Neurol Sci, 2019, 403, pp.65-66. ⟨10.1016/j.jns.2019.06.014⟩ Article dans une revue hal-03677845v1
Age and time course of long-term motor and nonmotor complications in Parkinson disease Stéphane Prange,Teodor Danaila,Chloé Laurencin,Catherine Caire,Elise Metereauet al. Neurology, 2019, 92 (2), pp.e148-e160. ⟨10.1212/WNL.0000000000006737⟩ Article dans une revue hal-04151943v1
Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation Chloe Laurencin,Solveig Montaut,Christophe Vial,Lorraine Bernard,Sylvie Binet al. Journal of the Neurological Sciences, 2018, 392, pp.65-68. ⟨10.1016/j.jns.2018.07.004⟩ Article dans une revue istex hal-04548039v1
Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect Yann Nadjar,Ana Lucia Hütter-Moncada,Philippe Latour,Xavier Ayrignac,Elsa Kaphanet al. Orphanet Journal of Rare Diseases, 2018, 13 (1), pp.175. ⟨10.1186/s13023-018-0913-4⟩ Article dans une revue hal-03541909v1
Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1 Mathilde Renaud,Maria-Ceu Moreira,Bondo Ben Monga,Diana Rodriguez,Rabab Debset al. JAMA neurology, 2018, 75 (4), pp.495. ⟨10.1001/jamaneurol.2017.4373⟩ Article dans une revue hal-02438841v1
Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients Chloé Laurencin,Anne Sophie Brunet,Jérôme Dumortier,Laurence Lion-Francois,Stéphane Thoboiset al. European Neurology, 2017, 77 (1-2), pp.5-15. ⟨10.1159/000452658⟩ Article dans une revue hal-04172927v1
Pitfalls in ataxia with ocular motor apraxia type 1: pseudodominant inheritance and very late onset Chloé Laurencin,Mathieu Anheim,Lise Larrieu,Caroline Tilikete,Michel Koeniget al. Journal of Neurology, 2015, 262 (5), pp.1366-1368. ⟨10.1007/s00415-015-7717-4⟩ Article dans une revue hal-02009097v1
Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome: Table Chloé Laurencin,Nathalie André-Obadia,Jean-Philippe Camdessanché,François Mauguière,Elodie Onget al. Neurology, 2015, 85 (23), pp.2076-2078. ⟨10.1212/WNL.0000000000002037⟩ Article dans une revue hal-04188606v1

Poster de conférence (1)

Effect of levodopa in the interpretation of social interactions in people living with Parkinson's disease Teodor Danaila,Elise Metereau,Paul Jaulent,Océane Porte,Hélène Klingeret al. NeuroFrance, May 2023, Lyon, France. ⟨10.1038/s41598-021-97788-1.PMID:34535699⟩ Poster de conférence hal-04983911v1

Thèse (1)

Etude du système noradrenergique chez l'homme et dans la maladie de Parkinson Chloé Laurencin Neurosciences. Université Claude Bernard - Lyon I, 2023. Français. ⟨NNT : 2023LYO10332⟩ Thèse tel-04839402v1